Literature DB >> 6321651

The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence.

G Cohen.   

Abstract

The intracellular generation of reactive forms of reduced oxygen, namely, hydrogen peroxide, superoxide and hydroxyl radical, can damage dopamine neurons. Oxy-radicals, and hydrogen peroxide generated by monoamine oxidase, can contribute to increased rates of senescence of dopamine neurons in Parkinson's disease. The evidence that oxy-radicals and monoamine oxidase are potentially cytotoxic is reviewed, and a pathobiology of dopamine neuron senescence in Parkinson's disease is proposed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6321651

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  39 in total

1.  Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease.

Authors:  J Kalra; A H Rajput; S V Mantha; A K Chaudhary; K Prasad
Journal:  Mol Cell Biochem       Date:  1992-06-26       Impact factor: 3.396

Review 2.  Selegiline and Parkinson's disease. Protective and symptomatic considerations.

Authors:  L I Golbe; J W Langston; I Shoulson
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  The involvement of ethanol in the free radical reaction of 6-hydroxydopamine.

Authors:  F F Oldfield; D L Cowan; A Y Sun
Journal:  Neurochem Res       Date:  1991-01       Impact factor: 3.996

4.  Glutathione peroxidase in early and advanced Parkinson's disease.

Authors:  P Johannsen; G Velander; J Mai; E B Thorling; E Dupont
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

5.  Striopallidodentate calcifications: nosographic, neuropathological and clinical proposal. Case report.

Authors:  A Francia; L Calandriello; R Restante; G Palladini
Journal:  Ital J Neurol Sci       Date:  1996-04

6.  Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview.

Authors:  D Metodiewa; C Kośka
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

Review 7.  Perspectives on MAO-B in aging and neurological disease: where do we go from here?

Authors:  M Jyothi Kumar; Julie K Andersen
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

Review 8.  The pharmacology of Parkinson's disease: basic aspects and recent advances.

Authors:  M Da Prada; H H Keller; L Pieri; R Kettler; W E Haefely
Journal:  Experientia       Date:  1984-11-15

9.  Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.

Authors: 
Journal:  BMJ       Date:  1993-08-21

10.  Effects of low selenium diets on antioxidant status and MPTP toxicity in mice.

Authors:  M S Sutphin; T D Buckman
Journal:  Neurochem Res       Date:  1991-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.